Does AVAPRITINIB Cause Mobility decreased? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Mobility decreased have been filed in association with AVAPRITINIB (Ayvakit). This represents 0.3% of all adverse event reports for AVAPRITINIB.
26
Reports of Mobility decreased with AVAPRITINIB
0.3%
of all AVAPRITINIB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Mobility decreased From AVAPRITINIB?
Of the 26 reports, 1 (3.8%) resulted in death, 11 (42.3%) required hospitalization.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AVAPRITINIB. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does AVAPRITINIB Cause?
Fatigue (1,527)
Off label use (1,138)
Nausea (1,033)
Diarrhoea (886)
Swelling face (481)
Memory impairment (467)
Dizziness (458)
Vomiting (456)
Headache (454)
Asthenia (433)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which AVAPRITINIB Alternatives Have Lower Mobility decreased Risk?
AVAPRITINIB vs AVASTIN
AVAPRITINIB vs AVATROMBOPAG
AVAPRITINIB vs AVELOX
AVAPRITINIB vs AVELUMAB
AVAPRITINIB vs AVIBACTAM